Beyond the SUA levels, a recent intracoronary imaging study showed that the elevated activity of xanthine oxidoreductase (XOR), a rate-limiting enzyme in purine metabolism, was associated with coronary lipid-rich plaque in patients with a stable CAD [8]. Here, XDH is linked to coronary artery disorder.